Marker Therapeutics, Inc. (MRKR)

2.00 -0.07 (-3.38%) USD  |  NASDAQ  |  Jan 09, 16:00
2.05 +0.05 (+2.50%) Pre-Market: 20:00
More

Marker Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
AIM ImmunoTech, Inc. Upgrade